Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Bioresorbable Scaffolds and Novel Coronary Stents

02/03/2016

Steve Bailey discusses our current state of knowledge, our concerns and hopes for the future of bioresorbable scaffolds and novel coronary stents. 


Advertisement

Advertisement

Advertisement

News

Bleeding Risk Factors
Study: Bleeding Risk Underestimated in Patients With Cancer
09/19/2024
"In general, the risk of bleeding in patients with cancer receiving anticoagulation therapy is higher than in the general population. However, very little is known about the risk of bleeding in cancer patients without anticoagulation," says...
"In general, the risk of bleeding in patients with cancer receiving anticoagulation therapy is higher than in the general population. However, very little is known about the risk of bleeding in cancer patients without anticoagulation," says...
"In general, the risk of...
09/19/2024
Cath Lab Digest
Pulmonary Embolism
SPIRARE I Trial: Jupiter Endovascular Announces First Patients Successfully Treated in First Clinical Study of Vertex Pulmonary Embolectomy System Using Endoportal Control
09/19/2024
“In these first cases, the Vertex system was successful in safely navigating through the right heart and into the pulmonary vasculature, facilitating an efficient and effective pulmonary embolectomy with no safety issues,” said Professor...
“In these first cases, the Vertex system was successful in safely navigating through the right heart and into the pulmonary vasculature, facilitating an efficient and effective pulmonary embolectomy with no safety issues,” said Professor...
“In these first cases, the...
09/19/2024
Cath Lab Digest
Fibromuscular Dysplasia
Mount Sinai Study Could Lead to New Treatments for Fibromuscular Dysplasia
09/18/2024
Mount Sinai researchers have identified a key driver of a blood vessel disorder known as fibromuscular dysplasia (FMD) which affects up to five percent of the adult population and can lead to high blood pressure, heart attack, or stroke.
Mount Sinai researchers have identified a key driver of a blood vessel disorder known as fibromuscular dysplasia (FMD) which affects up to five percent of the adult population and can lead to high blood pressure, heart attack, or stroke.
Mount Sinai researchers have...
09/18/2024
Cath Lab Digest
AI
Brigham Researchers Use Machine Learning to Improve Cardiovascular Risk Assessment
09/18/2024
A transparent AI approach recalibrated the new PREVENT equations to provide a more tailored cardiovascular risk assessment in a local population.
A transparent AI approach recalibrated the new PREVENT equations to provide a more tailored cardiovascular risk assessment in a local population.
A transparent AI approach...
09/18/2024
Cath Lab Digest
Congenital Heart Disease
ACC: New Study Identifies Link Between Congenital Heart Disease Prevalence and High-Altitude Environments
09/18/2024
The global prevalence of congenital heart disease is higher among women who live in high altitudes, according to a new study being presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.
The global prevalence of congenital heart disease is higher among women who live in high altitudes, according to a new study being presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.
The global prevalence of...
09/18/2024
Cath Lab Digest
Carotid Stenting
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard Prime Carotid Stent System
09/18/2024
The PMA application is based on the overwhelmingly positive one-year data from the Company’s C-GUARDIANS pivotal clinical trial that were presented at the Leipzig Interventional Course (LINC) 2024 in May.
The PMA application is based on the overwhelmingly positive one-year data from the Company’s C-GUARDIANS pivotal clinical trial that were presented at the Leipzig Interventional Course (LINC) 2024 in May.
The PMA application is based on...
09/18/2024
Cath Lab Digest
Prevention
Yale Study: Jails Should Be a Focus of Cardiovascular Disease Prevention
09/18/2024
Individuals released from jail are more likely to have uncontrolled cardiovascular disease (CVD) risk factors than those released from prison, a new Yale-led study finds.
Individuals released from jail are more likely to have uncontrolled cardiovascular disease (CVD) risk factors than those released from prison, a new Yale-led study finds.
Individuals released from jail...
09/18/2024
Cath Lab Digest
Carotid Artery Revascularization
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
09/17/2024
Silk Road Medical, Inc., is a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Silk Road Medical, Inc., is a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Silk Road Medical, Inc., is a...
09/17/2024
Cath Lab Digest
Professional Training
Calling Clinicians: Dartmouth Health Announces Launch of Medical Device Innovations Training Program
09/17/2024
"The medical device ecosystem needs active clinicians to guide the development process at companies and regulatory agencies," says Aaron V. Kaplan, MD, FACC, FNAI. “This program will provide scholars with a deep understanding of the medical...
"The medical device ecosystem needs active clinicians to guide the development process at companies and regulatory agencies," says Aaron V. Kaplan, MD, FACC, FNAI. “This program will provide scholars with a deep understanding of the medical...
"The medical device ecosystem...
09/17/2024
Cath Lab Digest
Intravascular Imaging
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue Imaging System
09/17/2024
HyperVue is the first intravascular imaging technology to combine two important imaging technologies, DeepOCT and NIRS, while optimizing for image quality and procedural efficiency in the cath lab, including no-flush catheter prep, fast and...
HyperVue is the first intravascular imaging technology to combine two important imaging technologies, DeepOCT and NIRS, while optimizing for image quality and procedural efficiency in the cath lab, including no-flush catheter prep, fast and...
HyperVue is the first...
09/17/2024
Cath Lab Digest

Advertisement

Advertisement

Bleeding Risk Factors
Study: Bleeding Risk Underestimated in Patients With Cancer
09/19/2024
"In general, the risk of bleeding in patients with cancer receiving anticoagulation therapy is higher than in the general population. However, very little is known about the risk of bleeding in cancer patients without anticoagulation," says...
"In general, the risk of bleeding in patients with cancer receiving anticoagulation therapy is higher than in the general population. However, very little is known about the risk of bleeding in cancer patients without anticoagulation," says...
"In general, the risk of...
09/19/2024
Cath Lab Digest
Pulmonary Embolism
SPIRARE I Trial: Jupiter Endovascular Announces First Patients Successfully Treated in First Clinical Study of Vertex Pulmonary Embolectomy System Using Endoportal Control
09/19/2024
“In these first cases, the Vertex system was successful in safely navigating through the right heart and into the pulmonary vasculature, facilitating an efficient and effective pulmonary embolectomy with no safety issues,” said Professor...
“In these first cases, the Vertex system was successful in safely navigating through the right heart and into the pulmonary vasculature, facilitating an efficient and effective pulmonary embolectomy with no safety issues,” said Professor...
“In these first cases, the...
09/19/2024
Cath Lab Digest
Bangalore headshot
Author Interview
Outcomes With Treatment Interventions for Clot-In-Transit in Patients With Pulmonary Embolism: An Interview With Sripal Bangalore, MD, MHA
09/19/2024
Dr Sripal Bangalore shares background and insights on his JIC articles, “Outcomes With Treatment Interventions for Clot-In-Transit in Patients With Pulmonary Embolism: A Meta-Analysis” and “Comparing Upfront Catheter-Based Thrombectomy With...
Dr Sripal Bangalore shares background and insights on his JIC articles, “Outcomes With Treatment Interventions for Clot-In-Transit in Patients With Pulmonary Embolism: A Meta-Analysis” and “Comparing Upfront Catheter-Based Thrombectomy With...
Dr Sripal Bangalore shares...
09/19/2024
Journal of Invasive Cardiology
Fibromuscular Dysplasia
Mount Sinai Study Could Lead to New Treatments for Fibromuscular Dysplasia
09/18/2024
Mount Sinai researchers have identified a key driver of a blood vessel disorder known as fibromuscular dysplasia (FMD) which affects up to five percent of the adult population and can lead to high blood pressure, heart attack, or stroke.
Mount Sinai researchers have identified a key driver of a blood vessel disorder known as fibromuscular dysplasia (FMD) which affects up to five percent of the adult population and can lead to high blood pressure, heart attack, or stroke.
Mount Sinai researchers have...
09/18/2024
Cath Lab Digest
AI
Brigham Researchers Use Machine Learning to Improve Cardiovascular Risk Assessment
09/18/2024
A transparent AI approach recalibrated the new PREVENT equations to provide a more tailored cardiovascular risk assessment in a local population.
A transparent AI approach recalibrated the new PREVENT equations to provide a more tailored cardiovascular risk assessment in a local population.
A transparent AI approach...
09/18/2024
Cath Lab Digest
Congenital Heart Disease
ACC: New Study Identifies Link Between Congenital Heart Disease Prevalence and High-Altitude Environments
09/18/2024
The global prevalence of congenital heart disease is higher among women who live in high altitudes, according to a new study being presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.
The global prevalence of congenital heart disease is higher among women who live in high altitudes, according to a new study being presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.
The global prevalence of...
09/18/2024
Cath Lab Digest
Carotid Stenting
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard Prime Carotid Stent System
09/18/2024
The PMA application is based on the overwhelmingly positive one-year data from the Company’s C-GUARDIANS pivotal clinical trial that were presented at the Leipzig Interventional Course (LINC) 2024 in May.
The PMA application is based on the overwhelmingly positive one-year data from the Company’s C-GUARDIANS pivotal clinical trial that were presented at the Leipzig Interventional Course (LINC) 2024 in May.
The PMA application is based on...
09/18/2024
Cath Lab Digest
Prevention
Yale Study: Jails Should Be a Focus of Cardiovascular Disease Prevention
09/18/2024
Individuals released from jail are more likely to have uncontrolled cardiovascular disease (CVD) risk factors than those released from prison, a new Yale-led study finds.
Individuals released from jail are more likely to have uncontrolled cardiovascular disease (CVD) risk factors than those released from prison, a new Yale-led study finds.
Individuals released from jail...
09/18/2024
Cath Lab Digest
Carotid Artery Revascularization
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
09/17/2024
Silk Road Medical, Inc., is a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Silk Road Medical, Inc., is a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Silk Road Medical, Inc., is a...
09/17/2024
Cath Lab Digest
Professional Training
Calling Clinicians: Dartmouth Health Announces Launch of Medical Device Innovations Training Program
09/17/2024
"The medical device ecosystem needs active clinicians to guide the development process at companies and regulatory agencies," says Aaron V. Kaplan, MD, FACC, FNAI. “This program will provide scholars with a deep understanding of the medical...
"The medical device ecosystem needs active clinicians to guide the development process at companies and regulatory agencies," says Aaron V. Kaplan, MD, FACC, FNAI. “This program will provide scholars with a deep understanding of the medical...
"The medical device ecosystem...
09/17/2024
Cath Lab Digest

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement